image-title

Kirollos S. Hanna, PharmD, BCPS, BCOP

Oral oncolytics, or oral chemotherapies, have significantly impacted the treatment of cancer. They enable patients to conveniently manage treatment in their homes. Despite the rapid growth, therapeutic advances, novel mechanisms of actions, and improved outcomes associated with these agents, the dispensing process remains inadequate. As a result of rising drug costs and healthcare expenditures, payers have forced a “medically disintegrated” model of dispensing, limiting patients and practices to fill prescriptions through external mail-order pharmacies. Read more.

Read More
image-title
A recent study evaluated chest, head and neck cancer patients receiving radiation and determined that use of statin medications can reduce the risk of stroke by 32% (statistically significant).  The effects of radiation can cause scarring and thickening of the arteries, which can lead to blockages down the line; statins help protect the arteries and prevent those cardiovascular events. Read more here.
Read More
image-title

MISSION STATEMENT/PHILOPSOPHY:

Mission: To deliver cutting-edge, compassionate, integrated urologic care, supported by evidence-based medicine, that optimizes quality of life for our patients while increasing value to all stakeholders.

Vision: We will serve as the national leader in integrated urologic healthcare by setting the standard for patient experience, employee satisfaction, and provider excellence.

LOCATION(S):

43 total 

(https://www.njurology.com/locations/)

PRACTICE DETAILS:

97 providers (physicians, nurse practitioners)
780+ employees

QUALIFICATIONS/CREDENTIALS:

In the midst of ACHC accreditation 

DISPENSING TYPE:

In-office Dispensary

SERVICES PROVIDED:

Dispensing of oral oncolytics

WHY DID YOU JOIN NCODA? 

I joined so we would be able to gather additional resources to continue building our uro-oncology program around prostate cancer and provide patients with continuity of care

HOW DID YOU BECOME A MEMBER?

I completed the online application for membership.

HOW DID YOU HEAR ABOUT US?

I initially heard about NCODA from my colleague, Rob Ashford when he was with Bayer.

HOW CAN NCODA HELP YOU?

We’ve have found NCODA to have an unwavering commitment to patient care, from creating tangible patient resources to the energy spent ensuring patient treatment remains in-house from first fill to last fill. We like that NCODA is also fighting for us to be able to stay the course in providing the continuity of care that we and our patients have become accustomed to. In attending the last two NCODA Forum meetings their “Passion For Patients” mission has been quite evident and they’ve allowed for me to bring meaningful information and resources into our practice.

HOW WOULD YOU LIKE TO BE MORE INVOLVED WITH NCODA?

I enjoy being involved with the Nursing Committee and TSK committee and would be welcome to other opportunities that support our staff, so they are better able to support our patients.

WHAT ARE SOME CHALLENGES YOU FACE NOW OR WILL FACE IN THE FUTURE OF ONCOLOGY? 

Urology is “newer” to oncology management and education of our providers and staff is key to ongoing positive patient outcomes. PBM’s are a constant challenge in the oncology dispensing arena.

NJ Urology Staff

Read More

Written by: Neal Dave, PharmD and Julianne Orr, PharmD NCODA Spring Forum PQI Workshop
Download Here

Opioids are commonly utilized in the management of moderate to severe cancer pain. Constipation is a major side effect of opioid administration and should be assessed and managed by the healthcare team.
Continue reading Opioid Induced Constipation (OIC)

Read More